BIOGEN IDEC revenue breakdown overview

BIOGEN IDEC revenue for the last year amounted to 8.28 B CHF, the most of which — 8.28 B CHF — came from its highest performing source at the moment, Innovative Therapies, the year earlier bringing 9.41 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought BIOGEN IDEC 4.57 B CHF, and the year before that — 5.12 B CHF.